injectable
-
Extremities
Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA
Tactoset cleared by the FDA to be combined with autologous bone marrow aspirate, a core element for regenerative healing Anika…
Read More » -
Financial
Injectable Cement Market to Garner $2.29 Bn, Globally, by 2031 at 5.7% CAGR: Allied Market Research
Increase in the prevalence of chronic orthopedic diseases and surge in need for injectable cements have boosted the growth of…
Read More » -
Biologics
SmartTRAK Advances Medtech Market Insights Platform; Announces New Modules for Wound Care and Orthopedic/Spine Injectables
SmartTRAK, the leading global Medtech business and market insights platform in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy…
Read More » -
Biologics
Bone Solutions Launches Mg OSTEOINJECT Injectable Magnesium-Based Bone Void Filler
Colleyville, TX, January 25, 2022 / OrthoSpineNews / — Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville,…
Read More » -
Biologics
Anika Announces Successful Completion of First Human Surgical Procedure with Injectable HA-Based Bone Repair Therapy
August 13, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More » -
Top Stories
Injectable sponges used for first time to stop soldier’s bleeding
By Rob Verger A U.S. military surgical team used an innovative device to staunch the bleeding on a gunshot…
Read More » -
Recon
New Data From Oxford University Hospitals Demonstrate Superior Outcome With CERAMENT™ Antibiotic Eluting Bone Substitute Compared To Collagen And Calcium Sulfate In The Management Of Chronic Osteomyelitis
LUND, Sweden, Oct. 6, 2015 /PRNewswire/ — BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument…
Read More » -
Hospitals
GRAFTYS Announces the Extension of its CE Mark for Its Calcium Phosphate Cements to Now Include GRAFTYS® HBS and GRAFTYS® Quickset for the Indication of Subchondral Bone Marrow Lesions around the Knee Joint (BML)
GRAFTYS SA, a company focused on development and commercialization of orthopedic biomaterials, is pleased to announce that it has obtained…
Read More » -
Spine
FDA Approves Injectable Device for Back, Leg Pain
By Susan Jeffrey Medscape Medical News Dec. 4, 2014 — The FDA has approved an injectable microchip nerve-stimulation device…
Read More »